nodes	percent_of_prediction	percent_of_DWPC	metapath
Naloxone—CREB1—epithelium—rectum cancer	0.0609	0.0742	CbGeAlD
Naloxone—TLR4—lymph node—rectum cancer	0.0601	0.0733	CbGeAlD
Naloxone—CREB1—smooth muscle tissue—rectum cancer	0.0586	0.0715	CbGeAlD
Naloxone—CREB1—renal system—rectum cancer	0.0564	0.0689	CbGeAlD
Naloxone—CREB1—urethra—rectum cancer	0.0554	0.0676	CbGeAlD
Naloxone—CREB1—mammalian vulva—rectum cancer	0.0528	0.0644	CbGeAlD
Naloxone—CREB1—female reproductive system—rectum cancer	0.0452	0.0551	CbGeAlD
Naloxone—OPRD1—renal system—rectum cancer	0.0446	0.0544	CbGeAlD
Naloxone—CREB1—vagina—rectum cancer	0.0409	0.0499	CbGeAlD
Naloxone—OPRK1—female reproductive system—rectum cancer	0.0343	0.0418	CbGeAlD
Naloxone—CREB1—lymph node—rectum cancer	0.0264	0.0323	CbGeAlD
Naloxone—SLCO1A2—renal system—rectum cancer	0.0262	0.032	CbGeAlD
Naloxone—ESR1—epithelium—rectum cancer	0.024	0.0292	CbGeAlD
Naloxone—ESR1—smooth muscle tissue—rectum cancer	0.0231	0.0282	CbGeAlD
Naloxone—ESR1—renal system—rectum cancer	0.0222	0.0271	CbGeAlD
Naloxone—CYP2C8—renal system—rectum cancer	0.0183	0.0223	CbGeAlD
Naloxone—ESR1—female reproductive system—rectum cancer	0.0178	0.0217	CbGeAlD
Naloxone—ESR1—vagina—rectum cancer	0.0161	0.0196	CbGeAlD
Naloxone—CYP2C8—female reproductive system—rectum cancer	0.0147	0.0179	CbGeAlD
Naloxone—CREB1—VEGFR3 signaling in lymphatic endothelium—ITGA2—rectum cancer	0.0135	0.0747	CbGpPWpGaD
Naloxone—CYP2C8—vagina—rectum cancer	0.0133	0.0162	CbGeAlD
Naloxone—CYP3A4—renal system—rectum cancer	0.0124	0.0151	CbGeAlD
Naloxone—ALB—lymph node—rectum cancer	0.0122	0.0149	CbGeAlD
Naloxone—ABCB1—seminal vesicle—rectum cancer	0.0109	0.0133	CbGeAlD
Naloxone—ESR1—lymph node—rectum cancer	0.0104	0.0127	CbGeAlD
Naloxone—CYP3A4—female reproductive system—rectum cancer	0.00993	0.0121	CbGeAlD
Naloxone—ABCB1—epithelium—rectum cancer	0.00946	0.0115	CbGeAlD
Naloxone—ABCB1—renal system—rectum cancer	0.00878	0.0107	CbGeAlD
Naloxone—ABCB1—urethra—rectum cancer	0.00862	0.0105	CbGeAlD
Naloxone—CREB1—Interleukin-11 Signaling Pathway—ITGA2—rectum cancer	0.00857	0.0475	CbGpPWpGaD
Naloxone—ABCB1—mammalian vulva—rectum cancer	0.00821	0.01	CbGeAlD
Naloxone—ABCB1—female reproductive system—rectum cancer	0.00703	0.00857	CbGeAlD
Naloxone—ABCB1—vagina—rectum cancer	0.00636	0.00775	CbGeAlD
Naloxone—CREB1—miRNAs involved in DNA damage response—TP53—rectum cancer	0.00436	0.0242	CbGpPWpGaD
Naloxone—ABCB1—lymph node—rectum cancer	0.00411	0.00502	CbGeAlD
Naloxone—SLCO1A2—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	0.00397	0.022	CbGpPWpGaD
Naloxone—CREB1—Trk receptor signaling mediated by the MAPK pathway—NRAS—rectum cancer	0.00296	0.0164	CbGpPWpGaD
Naloxone—CREB1—Trk receptor signaling mediated by PI3K and PLC-gamma—NRAS—rectum cancer	0.00283	0.0157	CbGpPWpGaD
Naloxone—CREB1—Trk receptor signaling mediated by the MAPK pathway—KRAS—rectum cancer	0.00255	0.0141	CbGpPWpGaD
Naloxone—CREB1—CREB phosphorylation through the activation of Ras—HRAS—rectum cancer	0.00246	0.0136	CbGpPWpGaD
Naloxone—CREB1—Trk receptor signaling mediated by PI3K and PLC-gamma—KRAS—rectum cancer	0.00243	0.0135	CbGpPWpGaD
Naloxone—TLR4—Spinal Cord Injury—TP53—rectum cancer	0.0024	0.0133	CbGpPWpGaD
Naloxone—CREB1—Nongenotropic Androgen signaling—HRAS—rectum cancer	0.00233	0.0129	CbGpPWpGaD
Naloxone—CREB1—Signaling mediated by p38-alpha and p38-beta—TP53—rectum cancer	0.00221	0.0123	CbGpPWpGaD
Naloxone—CREB1—p38 MAPK Signaling Pathway—HRAS—rectum cancer	0.00217	0.012	CbGpPWpGaD
Naloxone—CREB1—Trk receptor signaling mediated by the MAPK pathway—HRAS—rectum cancer	0.00217	0.012	CbGpPWpGaD
Naloxone—CREB1—Trk receptor signaling mediated by PI3K and PLC-gamma—HRAS—rectum cancer	0.00207	0.0115	CbGpPWpGaD
Naloxone—CREB1—Post NMDA receptor activation events—HRAS—rectum cancer	0.00202	0.0112	CbGpPWpGaD
Naloxone—SLCO1A2—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.00202	0.0112	CbGpPWpGaD
Naloxone—CREB1—ATM Signaling Pathway—TP53—rectum cancer	0.00199	0.011	CbGpPWpGaD
Naloxone—CREB1—Signaling events regulated by Ret tyrosine kinase—HRAS—rectum cancer	0.00194	0.0108	CbGpPWpGaD
Naloxone—ALB—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	0.00194	0.0107	CbGpPWpGaD
Naloxone—CREB1—LKB1 signaling events—TP53—rectum cancer	0.00188	0.0104	CbGpPWpGaD
Naloxone—CREB1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—rectum cancer	0.00186	0.0103	CbGpPWpGaD
Naloxone—CREB1—Interleukin-11 Signaling Pathway—HRAS—rectum cancer	0.00176	0.00978	CbGpPWpGaD
Naloxone—CREB1—Axon guidance—ITGA2—rectum cancer	0.00174	0.00963	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—TYMS—rectum cancer	0.00172	0.00952	CbGpPWpGaD
Naloxone—CREB1—NCAM signaling for neurite out-growth—NRAS—rectum cancer	0.0017	0.00943	CbGpPWpGaD
Naloxone—ESR1—Plasma membrane estrogen receptor signaling—NRAS—rectum cancer	0.00167	0.00926	CbGpPWpGaD
Naloxone—CREB1—Circadian rythm related genes—TYMS—rectum cancer	0.00165	0.00914	CbGpPWpGaD
Naloxone—ESR1—Aryl Hydrocarbon Receptor—NRAS—rectum cancer	0.00152	0.00845	CbGpPWpGaD
Naloxone—CREB1—Oncostatin M Signaling Pathway—KRAS—rectum cancer	0.00152	0.00842	CbGpPWpGaD
Naloxone—CREB1—NCAM signaling for neurite out-growth—KRAS—rectum cancer	0.00146	0.00812	CbGpPWpGaD
Naloxone—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—rectum cancer	0.00145	0.00804	CbGpPWpGaD
Naloxone—ESR1—Plasma membrane estrogen receptor signaling—KRAS—rectum cancer	0.00144	0.00797	CbGpPWpGaD
Naloxone—CREB1—Oncostatin M Signaling Pathway—TP53—rectum cancer	0.00135	0.00748	CbGpPWpGaD
Naloxone—ESR1—Aryl Hydrocarbon Receptor—KRAS—rectum cancer	0.00131	0.00727	CbGpPWpGaD
Naloxone—CREB1—DNA Damage Response—TP53—rectum cancer	0.0013	0.00722	CbGpPWpGaD
Naloxone—CREB1—G1 to S cell cycle control—TP53—rectum cancer	0.0013	0.00722	CbGpPWpGaD
Naloxone—CREB1—Oncostatin M Signaling Pathway—HRAS—rectum cancer	0.00129	0.00715	CbGpPWpGaD
Naloxone—CREB1—TSH signaling pathway—HRAS—rectum cancer	0.00127	0.00707	CbGpPWpGaD
Naloxone—CREB1—AP-1 transcription factor network—TP53—rectum cancer	0.00127	0.00705	CbGpPWpGaD
Naloxone—CREB1—miRNA Regulation of DNA Damage Response—TP53—rectum cancer	0.00126	0.00697	CbGpPWpGaD
Naloxone—CREB1—NCAM signaling for neurite out-growth—HRAS—rectum cancer	0.00124	0.0069	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—ITGA2—rectum cancer	0.00124	0.00687	CbGpPWpGaD
Naloxone—ESR1—LKB1 signaling events—TP53—rectum cancer	0.00123	0.00682	CbGpPWpGaD
Naloxone—ESR1—Plasma membrane estrogen receptor signaling—HRAS—rectum cancer	0.00122	0.00678	CbGpPWpGaD
Naloxone—CREB1—ErbB1 downstream signaling—NRAS—rectum cancer	0.0012	0.00666	CbGpPWpGaD
Naloxone—CREB1—Leptin signaling pathway—HRAS—rectum cancer	0.00115	0.00638	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—TYMS—rectum cancer	0.00112	0.00624	CbGpPWpGaD
Naloxone—CREB1—Glucocorticoid receptor regulatory network—TP53—rectum cancer	0.00112	0.00621	CbGpPWpGaD
Naloxone—ESR1—Aryl Hydrocarbon Receptor—HRAS—rectum cancer	0.00111	0.00618	CbGpPWpGaD
Naloxone—CREB1—ErbB1 downstream signaling—KRAS—rectum cancer	0.00103	0.00574	CbGpPWpGaD
Naloxone—CREB1—TCR Signaling Pathway—HRAS—rectum cancer	0.000994	0.00551	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.000985	0.00546	CbGpPWpGaD
Naloxone—CREB1—Signaling by SCF-KIT—NRAS—rectum cancer	0.000949	0.00526	CbGpPWpGaD
Naloxone—CREB1—B Cell Receptor Signaling Pathway—HRAS—rectum cancer	0.000936	0.00519	CbGpPWpGaD
Naloxone—CREB1—Downstream signaling of activated FGFR—NRAS—rectum cancer	0.000908	0.00504	CbGpPWpGaD
Naloxone—CREB1—Signaling by ERBB4—NRAS—rectum cancer	0.000893	0.00496	CbGpPWpGaD
Naloxone—CREB1—Signaling by NOTCH—TP53—rectum cancer	0.000892	0.00495	CbGpPWpGaD
Naloxone—TLR4—Innate Immune System—NRAS—rectum cancer	0.00088	0.00488	CbGpPWpGaD
Naloxone—CREB1—ErbB1 downstream signaling—HRAS—rectum cancer	0.000879	0.00487	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.000863	0.00479	CbGpPWpGaD
Naloxone—CREB1—Downstream signal transduction—NRAS—rectum cancer	0.000853	0.00473	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR—NRAS—rectum cancer	0.000849	0.00471	CbGpPWpGaD
Naloxone—CREB1—Signaling by ERBB2—NRAS—rectum cancer	0.000845	0.00469	CbGpPWpGaD
Naloxone—CREB1—DAP12 signaling—NRAS—rectum cancer	0.000841	0.00466	CbGpPWpGaD
Naloxone—ESR1—AP-1 transcription factor network—TP53—rectum cancer	0.000832	0.00462	CbGpPWpGaD
Naloxone—CREB1—Downstream signaling events of B Cell Receptor (BCR)—NRAS—rectum cancer	0.000829	0.0046	CbGpPWpGaD
Naloxone—CREB1—Signaling by SCF-KIT—KRAS—rectum cancer	0.000817	0.00453	CbGpPWpGaD
Naloxone—CREB1—Fc epsilon receptor (FCERI) signaling—NRAS—rectum cancer	0.000791	0.00439	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR in disease—NRAS—rectum cancer	0.000791	0.00439	CbGpPWpGaD
Naloxone—CREB1—DAP12 interactions—NRAS—rectum cancer	0.000791	0.00439	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR—NRAS—rectum cancer	0.000784	0.00435	CbGpPWpGaD
Naloxone—CREB1—Downstream signaling of activated FGFR—KRAS—rectum cancer	0.000781	0.00433	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR in Cancer—NRAS—rectum cancer	0.000777	0.00431	CbGpPWpGaD
Naloxone—CREB1—Signaling by PDGF—NRAS—rectum cancer	0.000774	0.00429	CbGpPWpGaD
Naloxone—CREB1—Integrated Breast Cancer Pathway—KRAS—rectum cancer	0.000773	0.00429	CbGpPWpGaD
Naloxone—CREB1—Signaling by ERBB4—KRAS—rectum cancer	0.000769	0.00427	CbGpPWpGaD
Naloxone—TLR4—Innate Immune System—KRAS—rectum cancer	0.000758	0.0042	CbGpPWpGaD
Naloxone—ESR1—Leptin signaling pathway—HRAS—rectum cancer	0.000753	0.00418	CbGpPWpGaD
Naloxone—CREB1—Downstream signal transduction—KRAS—rectum cancer	0.000734	0.00407	CbGpPWpGaD
Naloxone—OPRM1—TCR Signaling Pathway—HRAS—rectum cancer	0.000734	0.00407	CbGpPWpGaD
Naloxone—CREB1—B Cell Activation—NRAS—rectum cancer	0.000732	0.00406	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR—KRAS—rectum cancer	0.000731	0.00405	CbGpPWpGaD
Naloxone—CREB1—EGF/EGFR Signaling Pathway—KRAS—rectum cancer	0.000731	0.00405	CbGpPWpGaD
Naloxone—CREB1—Signaling by ERBB2—KRAS—rectum cancer	0.000727	0.00403	CbGpPWpGaD
Naloxone—CREB1—DAP12 signaling—KRAS—rectum cancer	0.000724	0.00401	CbGpPWpGaD
Naloxone—CREB1—Downstream signaling events of B Cell Receptor (BCR)—KRAS—rectum cancer	0.000713	0.00396	CbGpPWpGaD
Naloxone—CREB1—NGF signalling via TRKA from the plasma membrane—NRAS—rectum cancer	0.000701	0.00389	CbGpPWpGaD
Naloxone—CREB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—rectum cancer	0.000698	0.00387	CbGpPWpGaD
Naloxone—CREB1—Signaling by SCF-KIT—HRAS—rectum cancer	0.000694	0.00385	CbGpPWpGaD
Naloxone—CREB1—Integrated Breast Cancer Pathway—TP53—rectum cancer	0.000687	0.00381	CbGpPWpGaD
Naloxone—CREB1—BDNF signaling pathway—HRAS—rectum cancer	0.000683	0.00379	CbGpPWpGaD
Naloxone—CREB1—Fc epsilon receptor (FCERI) signaling—KRAS—rectum cancer	0.000681	0.00378	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR in disease—KRAS—rectum cancer	0.000681	0.00378	CbGpPWpGaD
Naloxone—CREB1—DAP12 interactions—KRAS—rectum cancer	0.000681	0.00378	CbGpPWpGaD
Naloxone—CREB1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—rectum cancer	0.000677	0.00376	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR—KRAS—rectum cancer	0.000675	0.00374	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR in Cancer—KRAS—rectum cancer	0.000669	0.00371	CbGpPWpGaD
Naloxone—CREB1—Signaling by PDGF—KRAS—rectum cancer	0.000666	0.00369	CbGpPWpGaD
Naloxone—CREB1—Downstream signaling of activated FGFR—HRAS—rectum cancer	0.000664	0.00368	CbGpPWpGaD
Naloxone—CREB1—Signaling by ERBB4—HRAS—rectum cancer	0.000654	0.00363	CbGpPWpGaD
Naloxone—TLR4—Innate Immune System—HRAS—rectum cancer	0.000644	0.00357	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	0.000641	0.00355	CbGpPWpGaD
Naloxone—CREB1—B Cell Activation—KRAS—rectum cancer	0.00063	0.0035	CbGpPWpGaD
Naloxone—CREB1—Downstream signal transduction—HRAS—rectum cancer	0.000624	0.00346	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR—HRAS—rectum cancer	0.000621	0.00345	CbGpPWpGaD
Naloxone—CREB1—EGF/EGFR Signaling Pathway—HRAS—rectum cancer	0.000621	0.00345	CbGpPWpGaD
Naloxone—CREB1—Signaling by ERBB2—HRAS—rectum cancer	0.000618	0.00343	CbGpPWpGaD
Naloxone—CREB1—DAP12 signaling—HRAS—rectum cancer	0.000615	0.00341	CbGpPWpGaD
Naloxone—CREB1—Downstream signaling events of B Cell Receptor (BCR)—HRAS—rectum cancer	0.000606	0.00336	CbGpPWpGaD
Naloxone—CREB1—NGF signalling via TRKA from the plasma membrane—KRAS—rectum cancer	0.000603	0.00334	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—rectum cancer	0.000595	0.0033	CbGpPWpGaD
Naloxone—ESR1—Signaling by ERBB4—NRAS—rectum cancer	0.000585	0.00325	CbGpPWpGaD
Naloxone—CREB1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—rectum cancer	0.000583	0.00323	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR in disease—HRAS—rectum cancer	0.000579	0.00321	CbGpPWpGaD
Naloxone—CREB1—DAP12 interactions—HRAS—rectum cancer	0.000579	0.00321	CbGpPWpGaD
Naloxone—CREB1—Fc epsilon receptor (FCERI) signaling—HRAS—rectum cancer	0.000579	0.00321	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR—HRAS—rectum cancer	0.000573	0.00318	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	0.000569	0.00316	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR in Cancer—HRAS—rectum cancer	0.000568	0.00315	CbGpPWpGaD
Naloxone—CREB1—Signaling by PDGF—HRAS—rectum cancer	0.000566	0.00314	CbGpPWpGaD
Naloxone—CREB1—Circadian rythm related genes—TP53—rectum cancer	0.000547	0.00303	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—NRAS—rectum cancer	0.000539	0.00299	CbGpPWpGaD
Naloxone—CREB1—B Cell Activation—HRAS—rectum cancer	0.000536	0.00297	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—TP53—rectum cancer	0.000527	0.00292	CbGpPWpGaD
Naloxone—CREB1—Transmission across Chemical Synapses—HRAS—rectum cancer	0.000525	0.00291	CbGpPWpGaD
Naloxone—TLR4—Immune System—NRAS—rectum cancer	0.000513	0.00284	CbGpPWpGaD
Naloxone—CREB1—NGF signalling via TRKA from the plasma membrane—HRAS—rectum cancer	0.000513	0.00284	CbGpPWpGaD
Naloxone—ESR1—Integrated Breast Cancer Pathway—KRAS—rectum cancer	0.000506	0.00281	CbGpPWpGaD
Naloxone—ESR1—Signaling by ERBB4—KRAS—rectum cancer	0.000504	0.00279	CbGpPWpGaD
Naloxone—CREB1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—rectum cancer	0.000495	0.00275	CbGpPWpGaD
Naloxone—CREB1—Axon guidance—NRAS—rectum cancer	0.000488	0.00271	CbGpPWpGaD
Naloxone—ALB—Hemostasis—ITGA2—rectum cancer	0.00048	0.00267	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—KRAS—rectum cancer	0.000464	0.00257	CbGpPWpGaD
Naloxone—ESR1—Integrated Breast Cancer Pathway—TP53—rectum cancer	0.00045	0.0025	CbGpPWpGaD
Naloxone—TLR4—Immune System—KRAS—rectum cancer	0.000441	0.00245	CbGpPWpGaD
Naloxone—ESR1—Signaling by ERBB4—HRAS—rectum cancer	0.000428	0.00238	CbGpPWpGaD
Naloxone—CREB1—Axon guidance—KRAS—rectum cancer	0.00042	0.00233	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	0.00042	0.00233	CbGpPWpGaD
Naloxone—CREB1—Neuronal System—HRAS—rectum cancer	0.000402	0.00223	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—HRAS—rectum cancer	0.000394	0.00219	CbGpPWpGaD
Naloxone—TLR4—Immune System—HRAS—rectum cancer	0.000375	0.00208	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	0.000373	0.00207	CbGpPWpGaD
Naloxone—CREB1—Axon guidance—HRAS—rectum cancer	0.000357	0.00198	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—NRAS—rectum cancer	0.000348	0.00193	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—NRAS—rectum cancer	0.000307	0.0017	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—KRAS—rectum cancer	0.000299	0.00166	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—NRAS—rectum cancer	0.000295	0.00164	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—KRAS—rectum cancer	0.000265	0.00147	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—TYMS—rectum cancer	0.000258	0.00143	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—HRAS—rectum cancer	0.000255	0.00141	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—KRAS—rectum cancer	0.000254	0.00141	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—HRAS—rectum cancer	0.000225	0.00125	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	0.000222	0.00123	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—HRAS—rectum cancer	0.000216	0.0012	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	0.000197	0.00109	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—NRAS—rectum cancer	0.000196	0.00109	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—NRAS—rectum cancer	0.000195	0.00108	CbGpPWpGaD
Naloxone—CREB1—Immune System—NRAS—rectum cancer	0.000179	0.000993	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—NRAS—rectum cancer	0.000171	0.00095	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—KRAS—rectum cancer	0.000169	0.000935	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—KRAS—rectum cancer	0.000168	0.000932	CbGpPWpGaD
Naloxone—CREB1—Disease—NRAS—rectum cancer	0.000165	0.000917	CbGpPWpGaD
Naloxone—CREB1—Immune System—KRAS—rectum cancer	0.000154	0.000855	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—KRAS—rectum cancer	0.000147	0.000818	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—NRAS—rectum cancer	0.000145	0.000803	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—HRAS—rectum cancer	0.000143	0.000795	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—HRAS—rectum cancer	0.000143	0.000793	CbGpPWpGaD
Naloxone—CREB1—Disease—KRAS—rectum cancer	0.000142	0.000789	CbGpPWpGaD
Naloxone—ALB—Hemostasis—NRAS—rectum cancer	0.000135	0.000749	CbGpPWpGaD
Naloxone—CREB1—Immune System—HRAS—rectum cancer	0.000131	0.000726	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—TYMS—rectum cancer	0.000127	0.000704	CbGpPWpGaD
Naloxone—ALB—Metabolism—TYMS—rectum cancer	0.000126	0.0007	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—HRAS—rectum cancer	0.000125	0.000695	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—KRAS—rectum cancer	0.000125	0.000691	CbGpPWpGaD
Naloxone—CREB1—Disease—HRAS—rectum cancer	0.000121	0.000671	CbGpPWpGaD
Naloxone—ALB—Hemostasis—KRAS—rectum cancer	0.000116	0.000645	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—NRAS—rectum cancer	0.000116	0.000642	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—NRAS—rectum cancer	0.000115	0.00064	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—TYMS—rectum cancer	0.000111	0.000614	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—HRAS—rectum cancer	0.000106	0.000587	CbGpPWpGaD
Naloxone—ALB—Hemostasis—TP53—rectum cancer	0.000103	0.000573	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—NRAS—rectum cancer	0.000101	0.000561	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—KRAS—rectum cancer	9.96e-05	0.000553	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—KRAS—rectum cancer	9.93e-05	0.000551	CbGpPWpGaD
Naloxone—ALB—Hemostasis—HRAS—rectum cancer	9.88e-05	0.000548	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—TP53—rectum cancer	8.85e-05	0.000491	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—TP53—rectum cancer	8.82e-05	0.00049	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—KRAS—rectum cancer	8.71e-05	0.000483	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—NRAS—rectum cancer	8.55e-05	0.000474	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—HRAS—rectum cancer	8.47e-05	0.00047	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—HRAS—rectum cancer	8.44e-05	0.000468	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—TP53—rectum cancer	7.74e-05	0.000429	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—NRAS—rectum cancer	7.58e-05	0.000421	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—HRAS—rectum cancer	7.4e-05	0.000411	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—KRAS—rectum cancer	7.36e-05	0.000408	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—TYMS—rectum cancer	6.82e-05	0.000378	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TP53—rectum cancer	6.54e-05	0.000363	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—KRAS—rectum cancer	6.52e-05	0.000362	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—HRAS—rectum cancer	6.25e-05	0.000347	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TP53—rectum cancer	5.8e-05	0.000322	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—HRAS—rectum cancer	5.55e-05	0.000308	CbGpPWpGaD
